S. Sonis

R. Soiffer, Stephanie J. Lee, S. Sonis, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chapter 11 – Oral and Maxillofacial Surgery

S. Sonis, B. Padwa, 2015 .

Orthodontic management of selected medically compromised patients: Cardiac disease, bleeding disorders, and asthma

S. Sonis, 2004 .

Oral Complications of Cancer and Their Treatment

S. Sonis, A. Yuan, A. yuan, 2017 .

Oral complications of cancer therapies. Pretreatment oral assessment.

S. Sonis, P. Woods, B. A. White, 1990, NCI monographs : a publication of the National Cancer Institute.

A clinically translatable mouse model for chemotherapy-related fatigue.

S. Sonis, E. Fey, J. Zombeck, 2013, Comparative medicine.

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

S. Sonis, A. Stringer, J. Bowen, 2007, Cancer treatment reviews.

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

D. Neuberg, R. Soiffer, S. Sonis, 2002, Bone Marrow Transplantation.

Genomics, Personalized Medicine and Oral Disease

S. Sonis, Dmsc, 2015, Springer International Publishing.

Oral leukoplakia remains a challenging condition.

A. Villa, S. Sonis, A. Villa, 2018, Oral diseases.

Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

S. Sonis, S. Elad, P. Bossi, 2020, Supportive Care in Cancer.

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

G. Oster, S. Sonis, M. Vera‐Llonch, 2006, Cancer.

Caspase-11 is not necessary for chemotherapy-induced intestinal mucositis.

Junying Yuan, S. Kang, S. Sonis, 2004, DNA and cell biology.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

A. Sultan, R. Tishler, A. Villa, 2017, The oncologist.

Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns

E. Schneider, A. Villa, S. Sonis, 2018, Cancer.

Inhibition of lymphoma cell proliferation by supernatant from fibrosarcoma cultures: preliminary evidence that the inhibitory material is prostaglandin E.

S. Sonis, R. Wilson, P. Stelos, 1977, Prostaglandins.

A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment

S. Sonis, 2021, Supportive Care in Cancer.

Transforming growth factor-β3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis

J. Haley, S. Sonis, A. Bruskin, 1997 .

Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3.

J. Haley, S. Sonis, A. Stewart, 1994, Cancer research.

Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients

O. Donini, S. Sonis, F. Worden, 2017, Biotechnology reports.

Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.

R. Feinn, A. Salner, U. Hegde, 2014, Oral oncology.

Assessment of oral mucositis in clinical trials: impact of training on evaluators in a multi-centre trial.

F. Spijkervet, J. Burgerhof, S. Sonis, 2005, European journal of cancer.

Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis

Michael S. Kramer, D. Knight, L. Murray, 2010, Fibrogenesis & tissue repair.

New thoughts on the pathobiology of regimen-related mucosal injury

A. Garden, S. Sonis, L. Anthony, 2006, Supportive Care in Cancer.

Links between regimen-related toxicities in patients being treated for colorectal cancer

M. Ramoni, S. Sonis, G. Aprile, 2009, Current opinion in supportive and palliative care.

Successful immunotherapy in a murine metastasizing fibrosarcoma model

S. Sonis, R. Wilson, L. A. Correa, 1984, Journal of surgical oncology.

Abstract P1-15-12: Single Nucleotide Polymorphism (SNP) Bayesian networks (BNs) Predict Risk of Chemotherapy-Induced Side Effects in Patients with Breast Cancer Receiving Dose Dense (DD) Doxorubicin/Cyclophosphamide Plus Paclitaxel (AC+T)

G. Alterovitz, S. Sonis, L. Schwartzberg, 2012 .

Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of Type 2 diabetes and obesity.

K. Ward, S. Sonis, C. Meyer, 2013, American journal of physiology. Renal physiology.

Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma.

J. Buatti, D. Mould, Yuhchyau Chen, 2018, International journal of radiation oncology, biology, physics.

Increased efficiency of immunotherapy using irradiated tumor cells

S. Sonis, Jin-min Wu, J. Fitzgerald, 2004, Cancer Immunology, Immunotherapy.

Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation.

A. Sultan, R. Soiffer, S. Sonis, 2017, Oral surgery, oral medicine, oral pathology and oral radiology.

Effects of Metal Poisoning on Five Liver Enzymes in the Killifish (Fundulus heteroclitus)

S. Sonis, E. Jackim, Janice M. Hamlin, 1970 .

Clinical presentation and management of mTOR inhibitor-associated stomatitis.

G. Demetri, S. George, S. Sonis, 2011, Oral oncology.

Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy.

S. Sonis, R. Logan, R. Gibson, 2007, Oral oncology.

Role of AMP-18 in oral mucositis.

M. Lingen, Peili Chen, S. Sonis, 2011, Oral oncology.

Polymorphonuclear leukocyte regulation of lymphocyte proliferation and differentiation.

S. Sonis, R. Wilson, J. Fitzgerald, 1983, Immunobiology.

Mucositis: biology and management

S. Sonis, N. Treister, 2007, Current opinion in otolaryngology & head and neck surgery.

Precision medicine for risk prediction of oral complications of cancer therapy–The example of oral mucositis in patients receiving radiation therapy for cancers of the head and neck

S. Sonis, 2022, Frontiers in Oral Health.

The application of “Omics” to accelerate precision medicine in Supportive Care in Cancer

S. Sonis, J. Patel, F. Ashbury, 2021, Supportive Care in Cancer.

The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis.

S. Sonis, J. Epstein, R. Popat, 2004, Oral oncology.

Management of oral mucositis in patients who have cancer.

S. Sonis, D. Peterson, R. Lalla, 2008, Dental clinics of North America.

Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, pathogenesis and prophylaxis of mucositis

C. Scully, S. Sonis, J. Epstein, 2003, Head & neck.

Topical Transforming Growth Factor-&bgr;3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors

S. Sonis, H. Schrezenmeier, P. Pouillart, 2001, Journal of immunotherapy.

Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy.

S. Sonis, M. Nicolson, S. Evitts, 1992, Oral surgery, oral medicine, and oral pathology.

Benzydamine HCL in the management of chemotherapy-induced mucositis. I. Pilot study.

P. Lockhart, S. Sonis, F. Clairmont, 1985, Journal of oral medicine.

SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients.

G. Alterovitz, S. Sonis, J. Antin, 2013, Oral diseases.

Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters.

J. Fiddes, S. Sonis, D. A. Steinberg, 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.

N. LeBoeuf, A. Villa, S. Sonis, 2021, Oral diseases.

Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung

L. Elting, S. Sonis, M. Brennan, 2015, Supportive Care in Cancer.

IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.

S. Sonis, R. Schaub, J. Keith, 1994, Stem cells.

Salen Mn complexes mitigate radiation injury in normal tissues.

P. Tofilon, R. Hill, S. Sonis, 2011, Anti-cancer agents in medicinal chemistry.

Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.

S. Sonis, M. Lerman, B. Watkins, 2009, Oral oncology.

Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider

A. Villa, S. Sonis, S. Fedele, 2022, Frontiers in Oral Health.

Using real world data to advance the provision of supportive cancer care: mucositis as a case study

S. Sonis, N. Blijlevens, H. Wardill, 2022, Current opinion in supportive and palliative care.

Management of Oral Mucositis in Patients with Cancer

S. Sonis, R. Lalla, E. Douglas, 2008 .

Recurrent aphthous ulcers: a review of diagnosis and treatment.

S. Sonis, S. Woo, Stephen T. Sonis, 1996, Journal of the American Dental Association.

Oral lichen planus: comparative efficacy and treatment costs—a systematic review

S. Sonis, H. Sroussi, N. Treister, 2022, BMC Oral Health.

Antimicrobial therapy to prevent or treat oral mucositis.

S. Sonis, J. Epstein, J. Donnelly, 2003, The Lancet. Infectious diseases.

Effects of ceramide inhibition on experimental radiation-induced oral mucositis.

S. Sonis, Debby Hwang, R. Popat, 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

The gene expression sequence of radiated mucosa in an animal mucositis model

J. Haley, S. Sonis, R. Brennan, 2002, Cell proliferation.

Leveraging GWAS Data Derived From a Large Cooperative Group Trial to Identify a SNP Cluster Associated With the Risk of Taxane-induced Peripheral Neuropathy

J. Fernández-Martínez, S. Sonis, B. Schneider, 2021 .

Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy.

P. Lockhart, S. Sonis, Stephen T. Sonis, 1979, Oral surgery, oral medicine, and oral pathology.

Evaluation of pain associated with oral mucositis during the acute period after administration of high‐dose chemotherapy

D. Cella, J. Wingard, F. Giles, 2003, Cancer.

Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11.

S. Sonis, J. O’Brien, A. Muska, 1995, European journal of cancer. Part B, Oral oncology.

A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients

S. Sonis, S. Woo, A. Sonis, 1993, Cancer.

Assessment of the need for treatment of postendodontic asymptomatic periapical radiolucencies in bone marrow transplant recipients.

S. Sonis, S. Woo, M. Monopoli, 1993, Oral surgery, oral medicine, and oral pathology.

Prevention and management of oral mucositis induced by antineoplastic therapy.

S. Sonis, J. Clark, John R. Clark, 1991, Oncology.

The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients

S. Sonis, S. Woo, A. Sonis, 1990, Cancer.

An animal model for mucositis induced by cancer chemotherapy.

G. Shklar, S. Sonis, J. Jenson, 1990, Oral surgery, oral medicine, and oral pathology.

Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies.

S. Sonis, A. Kunz, 1988, Oral surgery, oral medicine, and oral pathology.

Oral complications of cancer chemotherapy: present status and future studies.

S. Sonis, D. Peterson, 1982, Cancer treatment reports.

Oral complications of cancer chemotherapy in pediatric patients.

S. Sonis, A. Sonis, 1979, The Journal of pedodontics.

Oral complications in patients receiving treatment for malignancies other than of the head and neck.

S. Sonis, A. Sonis, A. Lieberman, 1978, Journal of the American Dental Association.

Emerging therapies for the prevention and treatment of oral mucositis

S. Sonis, A. yuan, 2014, Expert opinion on emerging drugs.

Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.

J. Peterson, M. Jeffers, S. Sonis, 2003, Clinical Cancer Research.

Preclinical Characterization of CG 53135 ( FGF-20 ) in Radiation and Concomitant Chemotherapy / Radiation-induced Oral Mucositis

J. Peterson, M. Jeffers, S. Sonis, 2003 .

Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease.

A. Villa, S. Sonis, D. Peterson, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Section Reviews: Biologicals & Immunologicals: Pharmacological attenuation of chemotherapy-induced oral mucositis

J. Haley, S. Sonis, 1996 .

Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis

S. Sonis, Stephen T. Sonis, 2009, Core evidence.

The quest for effective treatments of mucositis.

S. Sonis, 2011, The journal of supportive oncology.

Oral Complications of Cancer Chemotherapy

S. Sonis, D. Peterson, 2011, Developments in Oncology.

Treatment for Oral Mucositis—Current Options and an Update of Small Molecules Under Development

S. Sonis, 2021, Current Treatment Options in Oncology.

Oral Mucosal Complications of Cancer Therapy

S. Sonis, 2013 .

The Epidemiology and Risk Assessment of Mucositis

S. Sonis, 2012 .

Oral mucositis

S. Sonis, S. Sonis, 2011 .

Pharmacotherapy for the management of cancer regimen-related oral mucositis

A. Villa, S. Sonis, 2016, Expert opinion on pharmacotherapy.

Mucositis: pathobiology and management

A. Villa, S. Sonis, 2015, Current opinion in oncology.

Oral mucositis in head and neck cancer: risk, biology, and management.

S. Sonis, 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Interaction of Ia antigen-bearing polymorphonuclear leukocytes and murine splenocytes

S. Sonis, M. Rodrick, Richard E. Wilson, 1983, Inflammation.

Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters.

A. Dorner, C. Bedrosian, S. Sonis, 2000, Oral oncology.

The biological basis for the attenuation of mucositis: the example of interleukin-11

S. Sonis, L. Edwards, C. Lucey, 1999, Leukemia.

Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022

Michael R Hamblin, M. Hamblin, J. Bjordal, 2022, Frontiers in Oncology.

Methodes et compositions pour le traitement et la prevention des mucosites

S. Sonis, E. Fey, 1999 .

Predicting mucositis risk associated with cytotoxic cancer treatment regimens: rationale, complexity, and challenges

S. Sonis, Petra C. Bachour, Petra Bachour, 2018, Current opinion in supportive and palliative care.

Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy.

D. Rosenthal, S. Sonis, S. Gordon, 2019, Journal of the National Cancer Institute. Monographs.

A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy

G. Gordon, S. Sonis, D. Peterson, 2012, Supportive Care in Cancer.

Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease.

J. Crawford, S. Sonis, J. Ferrara, 1996, Transplantation.

Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis

A. Villa, S. Sonis, 2018, Expert opinion on investigational drugs.

Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies

G. Oster, S. Sonis, M. Vera‐Llonch, 2007, Supportive Care in Cancer.

The incidence of mast cells in selected oral lesions.

S. Sonis, H. Doku, H. C. Doku, 1972, Oral surgery, oral medicine, and oral pathology.

Multi‐institutional, randomized, double‐blind, placebo‐controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck

D. Heron, R. Carmel, S. Sonis, 2014, Cancer.

Emerging drugs for chemotherapy-induced mucositis

S. Sonis, J. Bowen, D. Keefe, 2008 .

Head and Neck Management of the Cancer Patient

S. Sonis, D. Peterson, E. Elias, 2011, Developments in Oncology.

Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients

G. Demetri, F. Haluska, S. Sonis, 2009, Cancer.

Can oral glutamine prevent mucositis in children undergoing hematopoietic stem-cell transplantation?

S. Sonis, 2006, Nature Clinical Practice Oncology.

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

R. Tishler, A. Mahadevan, A. Allen, 2009, Cancer.

Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy

B. Murphy, A. Colevas, S. Sonis, 2013, Cancer.

Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?

S. Sonis, 2005, Nature Clinical Practice Oncology.

Pathobiology of oral mucositis: novel insights and opportunities.

S. Sonis, 2007, The journal of supportive oncology.

Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Induced Mucositis

S. Sonis, 2021, Drug design, development and therapy.

GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling

J. Savage, S. Sonis, A. Pulsipher, 2021, PloS one.

Ultrasound-mediated drug delivery.

S. Sonis, 2017, Oral diseases.

A Comparison and Assessment of Scoring Scales for Mucositis

S. Sonis, 2012 .

Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis.

J. Haley, S. Sonis, A. Bruskin, 1997, Oral oncology.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana‐Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline

A. Sultan, R. Tishler, A. Villa, 2017, The oncologist.

Osseous Grafting Materials for Periodontal Defects

D. Wise, S. Sonis, D. Trantolo, 2003 .

A biological approach to mucositis.

S. Sonis, 2004, The journal of supportive oncology.

The Chicken or the Egg? Changes in Oral Microbiota as Cause or Consequence of Mucositis During Radiation Therapy

S. Sonis, 2017, EBioMedicine.

Biomarkers Associated with Lymphedema and Fibrosis in Patients with Cancer of the Head and Neck.

B. Murphy, M. Dietrich, S. Ridner, 2018, Lymphatic research and biology.

Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy

A. Barsevick, L. Elting, B. Koczwara, 2014, Cancer Chemotherapy and Pharmacology.

The pathogenesis of mucositis: updated perspectives and emerging targets.

A. Kandwal, S. Sonis, S. Elad, 2019, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

The pathobiology of mucositis.

S. Sonis, 2004, Nature reviews. Cancer.

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

D. McGuire, L. Elting, S. Sonis, 2014, Cancer.

Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs.

S. Sonis, A. Stringer, J. Bowen, 2008, Cancer biology & therapy.

Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis

S. Sonis, A. Stringer, J. Bowen, 2008, Cancer Chemotherapy and Pharmacology.

In Vitro Effects of Isobutyl Cyanoacrylate on Four Types of Bacteria

S. Sonis, J. Jandinski, John Jandinski, 1971, Journal of dental research.

Significance of the head and neck in late infection in renal transplant recipients.

G. Shklar, S. Sonis, E. Stoufi, 1986, Oral surgery, oral medicine, and oral pathology.

Lateral pharyngeal space abscess as a consequence of regional anesthesia.

S. Sonis, D. Kitay, N. Ferraro, 1991, Journal of the American Dental Association.

Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy

F. Spijkervet, S. Sonis, J. Epstein, 1999, Cancer.

An association between Crohn's disease, periodontal disease and enhanced neutrophil function.

S. Sonis, I. Lamster, A. Hannigan, 1978, Journal of periodontology.

Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis

Crispian Scully, C. Scully, S. Sonis, 2004, Head & neck.

Palliative Care and Complications of Cancer Therapy

Frauke Müller, Stephen T. Sonis, Martin Schimmel, 2013 .

Perspectives on cancer therapy‐induced mucosal injury

L. Elting, E. Rubenstein, B. Bekele, 2004, Cancer.

Cavernous sinus thrombosis and brain abscess initiated and maintained by periodontally involved teeth.

S. Sonis, D. Goteiner, R. Fasciano, 1982, Journal of oral medicine.

The pathobiology of mucositis

S. Sonis, 2004, Nature Reviews Cancer.

Attenuation of radiation- and chemoradiation-induced mucositis using gamma-D-glutamyl-L-tryptophan (SCV-07).

S. Sonis, E. Fey, B. Watkins, 2010, Oral diseases.

New thoughts on the initiation of mucositis.

S. Sonis, Stephen T. Sonis, 2010, Oral diseases.

Clinical Practice Guidelines for the Prevention and Treatment of Mucositis

D. McGuire, L. Elting, S. Sonis, 2007 .

Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

D. McGuire, L. Elting, E. Rubenstein, 2004, Cancer.

The antigenicity of electrocauterized allogeneic tumor cells in mice.

J. Collins, S. Sonis, D. Devereux, 1982, The Journal of surgical research.

Enhanced oral hygiene interventions as a risk mitigation strategy for the prevention of non-ventilator-associated pneumonia: a systematic review and meta-analysis

S. Sonis, S. Papatheodorou, P. Satheeshkumar, 2020, British Dental Journal.

An unusually located early peripheral ameloblastoma.

P. Lockhart, S. Sonis, S. Connolly, 1984, Journal of oral medicine.

Treatment of Plaque-induced Gingivitis, Chronic Periodontitis, and Other Clinical Conditions.

B. Mealey, R. Genco, J. Fiorellini, 2009, Pediatric dentistry.

New frontiers in the management of chemotherapy-induced mucositis.

F. Spijkervet, S. Sonis, 1998, Current opinion in oncology.

The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral Mucositis

W. London, S. Sonis, A. Yaroslavsky, 2021, Frontiers in Oral Health.

Emerging evidence on the pathobiology of mucositis

S. Sonis, S. Elad, R. Lalla, 2013, Supportive Care in Cancer.

Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study

S. Sonis, D. Peterson, R. Lalla, 2009, Supportive Care in Cancer.

Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers.

M. Ramoni, S. Sonis, R. Haddad, 2007, Oral oncology.

The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy.

S. Sonis, 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana‐Farber Cancer Institute, 2011 to 2019

A. Villa, S. Sonis, Yuan-Pei Xu, 2021, Cancer.

Circulating immune complexes in patients following clinically curative resection of colorectal cancer.

R. Mayer, G. Steele, S. Sonis, 1978, Surgery.

Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.

S. Sonis, N. Blijlevens, N Blijlevens, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

How should we measure and report radiotherapy-induced xerostomia?

D. Brizel, A. Eisbruch, B. Murphy, 2003, Seminars in radiation oncology.

New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury

S. Sonis, G. Parisi, G. Aprile, 2017, Front. Pharmacol..

AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis.

Bernard Coulie, S. Sonis, B. Coulie, 2010, Oral oncology.

The prevention and treatment of radiotherapy - induced xerostomia.

D. Brizel, A. Eisbruch, B. Murphy, 2003, Seminars in radiation oncology.

Comparison of the nature and frequency of medical problems among patients in general, specialty and hospital dental practices.

S. Sonis, D. Gottlieb, C. Vorhaus, 1983, Journal of oral medicine.

Oral health in cancer therapy.

S. Sonis, J. Epstein, D. Peterson, 2009, Texas dental journal.

Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy

A. Garden, R. Tishler, L. Elting, 2008, Cancer.

Principles and Practice of Oral Medicine

S. Sonis, L. Fang, R. Fazio, 1994 .

Personalized Medicine, Genomics and Oral Diseases: The Future

S. Sonis, 2015 .

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis.

S. Sonis, 2009, Oral oncology.

Validation of a Monte Carlo Modelling Based Dosimetry of Extraoral Photobiomodulation

W. London, S. Sonis, A. Yaroslavsky, 2021, Diagnostics.

Oral mucositis in cancer therapy.

S. Sonis, 2004, The journal of supportive oncology.

Subgingival and Tongue Microbiota during Early Periodontitis

R. Kent, S. Sonis, A. Tanner, 2006, Journal of dental research.

Epidemiology, Frequency, Distribution, Mechanisms, and Histopathology

S. Sonis, 1983 .

Oral pathoses as diagnostic indicators in leukemia.

S. Sonis, A. Sonis, P. Lockhart, 1980, Oral surgery, oral medicine, and oral pathology.

Emerging evidence on the pathobiology of mucositis

S. Sonis, S. Elad, R. Lalla, 2013, Supportive Care in Cancer.

Host-Microbiome Cross-talk in Oral Mucositis

N. Sanfilippo, S. Sonis, P. Corby, 2016, Journal of dental research.

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

N. Yarom, S. Sonis, Y. Zadik, 2021, CA: a cancer journal for clinicians.

Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study.

P. Lockhart, S. Sonis, P B Lockhart, 1981, The Journal of dermatologic surgery and oncology.

Current Approaches to the Management of Oral Mucositis

S. Sonis, 2012 .

Risk factors affecting hospital length of stay in patients with odontogenic maxillofacial infections.

S. Sonis, E. S. Peters, B. Fong, 1996, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study.

Oreola Donini, O. Donini, S. Sonis, 2016, Journal of biotechnology.

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.

S. Sonis, S T Sonis, 1998, Oral oncology.

Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations

Michael R Hamblin, I. Jacobi, L. Smeele, 2016, Supportive Care in Cancer.

Low level laser therapy / photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer : part 1 : mechanisms of action

Michael R Hamblin, I. Jacobi, L. Smeele, 2016 .

Oral Medicine referrals at a hospital-based practice in the United States.

A. Villa, S. Sonis, M. Lerman, 2015, Oral surgery, oral medicine, oral pathology and oral radiology.

Current understanding of the relationship between periodontal and systemic diseases

S. Sonis, H. Mawardi, Lena S. Elbadawi, 2015, Saudi medical journal.

Comparison of the nature and frequency of medical problems among patients in general, specialty and hospital dental practices.

S. Sonis, D. Gottlieb, C. Vorhaus, 1983, Annals of dentistry.

Clinical characteristics and microbiota of progressing slight chronic periodontitis in adults.

R. Kent, B. Paster, S. Sonis, 2007, Journal of clinical periodontology.

Mucosal injury in cancer patients : new strategies for research and treatment : proceedings of a multidisciplinary conference held in Bethesda, Maryland May 24-25, 2000

S. Sonis, 2001 .

Oral complications of multimodality therapy for advanced squamous cell carcinoma of head and neck.

P. Lockhart, S. Sonis, J. Clark, 1986, Oral surgery, oral medicine, and oral pathology.

Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation

S. Sonis, B. Watkins, G. Ara, 2008, International journal of radiation biology.

In vivo and in vitro effects of beta-carotene and algae extracts in murine tumor models.

S. Sonis, R. Wilson, J. Fitzgerald, 1989, Nutrition and cancer.

Genomic data integration in chronic lymphocytic leukemia

Enrique J. deAndrés-Galiana, Stephen T. Sonis, Juan Luis Fernández‐Martínez, 2017, The journal of gene medicine.

Pathobiology of Cancer Regimen-Related Toxicities

S. Sonis, D. Keefe, 2013, Springer New York.

Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm

Ana Cernea, Juan Luis Fernández-Martínez, J. Fernández-Martínez, 2017, Cancer medicine.

An analysis of dental services based in the emergency room.

R. Valachovic, S. Sonis, 1988, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

Management of dental trauma in children

S. Sonis, Dennis J. Mctique, 1986 .

Cancer, its Complications, and the Head and Neck

S. Sonis, 1986 .

Effects of metal poisoning on 5 liver enzymes in killifish (Fundulus heteroclitus). Journal of Fisheries Research Board of Canada .

S. Sonis, E. Jackim, J. Hamlin, 1970 .

Preservation of the alveolar ridge with hydroxyapatite-collagen implants in rats.

S. Sonis, D. Atwood, E. Hahn, 1988, The Journal of prosthetic dentistry.

Utilization of inpatient dental consultation services.

P. Lockhart, S. Sonis, 1981, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.

D. Miklos, D. Fisher, R. Soiffer, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized phase 2 trial of a novel clonidine mucoadhesive buccal tablet for the amelioration of oral mucositis in patients treated with concomitant chemo-radiotherapy for head and neck cancer.

A. Mazar, R. Kortmann, S. Sonis, 2020, International journal of radiation oncology, biology, physics.

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.

D. Neuberg, R. Soiffer, Stephanie J. Lee, 2002, Blood.

S. Sonis, E. De Carlo, G. Aprile, 2015, World journal of gastroenterology.

Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients.

S. Sonis, J. Epstein, J. Raber-Durlacher, 2016, Oral oncology.

Severe oral hemorrhage and sepsis following bone marrow transplant failure.

P. Lockhart, S. Sonis, S. Connolly, 1983, Oral surgery, oral medicine, and oral pathology.

S. Sonis, 2010, Current opinion in supportive and palliative care.

Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx Squamous Cell Carcinoma (OSCC)

D. Sher, J. Bianco, S. Sonis, 2020 .

Inflammation and genetic risk indicators for early periodontitis in adults.

R. Kent, S. Sonis, A. Tanner, 2011, Journal of periodontology.

Placebo effect in burning mouth syndrome: a systematic review.

S. Sonis, J. Kelley, M. Kuten-Shorrer, 2014, Oral diseases.

The effect of the immunomodulatory peptide gamma-D-glutamyl-L-tryptophan in leukemia, lymphoma, and head and neck cancer xenograft models.

S. Sonis, J. Papkoff, B. Watkins, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis

A. Giuliano, A. Villa, S. Sonis, 2021, Tumour virus research.

Oral Medicine Secrets

S. Sonis, L. Fang, R. Fazio, 2002 .

A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis

Jing Liu, Stephen T. Sonis, J. Fernández-Martínez, 2016, PloS one.

Disparities in Oral Cancer Screening Among Dental Professionals: NHANES 2011-2016.

R. Bergmark, A. Villa, S. Sonis, 2019, American Journal of Preventive Medicine.

Psoriasis and oral health in adult United States population: a cross-sectional study

S. Sonis, Y. Farag, Mai Hussein, 2023, BMC Oral Health.

Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis?

S. Sonis, Rui Amaral Mendes, 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients.

S. George, S. Sonis, M. Gallottini, 2013, Oral oncology.

Local and Systemic Pathogenesis and Consequences of Regimen-Induced Inflammatory Responses in Patients with Head and Neck Cancer Receiving Chemoradiation

S. Sonis, J. Raber-Durlacher, E. Russi, 2014, Mediators of inflammation.

Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters.

S. Sonis, P. Szklut, A. V. Van Vugt, 1997, Cytokine.

Sensitivity analysis of gene ranking methods in phenotype prediction

Enrique J. deAndrés-Galiana, Juan Luis Fernández Martínez, Stephen T. Sonis, 2016, J. Biomed. Informatics.

Cytokine‐mediated blood brain barrier disruption as a conduit for cancer/chemotherapy‐associated neurotoxicity and cognitive dysfunction

S. Sonis, K. Mander, J. Bowen, 2016, International journal of cancer.

On the pathogenesis of mTOR inhibitor-associated stomatitis (mIAS)-studies using an organotypic model of the oral mucosa.

S. Sonis, G. Lyng, P. W. Andreotta, 2017, Oral diseases.

An analysis of peripheral blood and salivary polymorphonuclear leukocyte function, circulating immune complex levels and oral status in patients with inflammatory bowel disease.

S. Sonis, M. Rodrick, I. Lamster, 1982, Journal of periodontology.

Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.

S. Sonis, O. Nicolatou‐Galitis, Erofili Papadopoulou, 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

The effect of methotrexate on experimental salivary gland neoplasm in rats.

G. Shklar, S. Sonis, 1975, Archives of oral biology.

The Economic Burden of Toxicities Associated with Cancer Treatment: Review of the Literature and Analysis of Nausea and Vomiting, Diarrhoea, Oral Mucositis and Fatigue

Stephen T. Sonis, S. Sonis, Alan Carlotto, 2013, PharmacoEconomics.

Contrasting effects of alloandtiserum and xenoantiserum on cell-mediated lysis of tumor cells.

S. Sonis, R. Wilson, P. Stelos, 1975, Cellular immunology.

Impact of Microarray Preprocessing Techniques in Unraveling Biological Pathways

Enrique J. deAndrés-Galiana, Juan Luis Fernández Martínez, Leorey N. Saligan, 2016, J. Comput. Biol..

THE IMMUNE RESPONSE OF MICE REPEATEDLY INJECTED WITH ALLOGENEIC TUMOR CELLS

S. E. Bear, S. Sonis, R. Wilson, 1975, Transplantation.

Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis

K. Ward, S. Sonis, C. Meyer, 2014, Radiation research.

Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma

S. Sonis, N. Blijlevens, P. Satheeshkumar, 2023, Supportive Care in Cancer.

TNF and oral mucositis: response to effect of selective inhibitors of inflammation on oral mucositis: preclinical studies. Radiother Oncol 2009; 92:472-6.

S. Sonis, B. Fox, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effects of supernatants of polymorphonuclear neutrophils recruited by different inflammatory substances on mitogen responses of lymphocytes

S. Sonis, M. Rodrick, I. Lamster, 1982, Inflammation.

Animal Models of Toxicities Caused by Anti-Neoplastic Therapy

S. Sonis, G. Lyng, K. Pouliot, 2011 .

Animal Models of Oral Mucositis Induced by Antineoplastic Drugs and Radiation

S. Sonis, 2002 .

Assessment of Drug Sensitivity of Human Leukaemic Myeloblasts

I. Maclennan, T. R. Munro, S. Sonis, 1977, British Journal of Cancer.

Strategies to mitigate the toxicity of cancer therapeutics.

K. Blenman, S. Sonis, M. Lustberg, 2022, Advances in Cancer Research.

Healthcare-associated infections among patients hospitalized for cancers of the lip, oral cavity and pharynx

A. Villa, S. Sonis, Satheeshkumar P. Sankaran, 2021, Infection prevention in practice.

Tumor Outcomes for ROMAN: Phase 3 Trial of Avasopasem Manganese (GC4419) for Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiotherapy (CRT) for Locally Advanced Head and Neck Cancer (LAHNC)

V. King, J. Holmlund, N. Dunlap, 2022, International Journal of Radiation Oncology*Biology*Physics.

Exploring Genetic Attributions Underlying Radiotherapy-Induced Fatigue in Prostate Cancer Patients.

J. L. Fernández Martínez, S. Sonis, L. Saligan, 2017, Journal of pain and symptom management.

Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity.

S. Sonis, K. Mander, J. Bowen, 2015, Cancer treatment reviews.

Complications of Treatment Toll-like receptor 4 signaling : A common biological mechanism of regimen-related toxicities

S. Sonis, K. Mander, J. Bowen, 2015 .

Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy

M. Ramoni, S. Sonis, G. Aprile, 2008, Cancer.

An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis

A. Villa, S. Sonis, 2020, Expert opinion on pharmacotherapy.

Evidence suggesting the presence of antigen-antibody complexes on the surface of salivary leukocytes.

S. Sonis, R. Wilson, I. Lamster, 1979, Journal of periodontal research.

Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.

I. Maclennan, S. Sonis, R. Falcão, 1977, British Journal of Cancer.

Supervised Classification by Filter Methods and Recursive Feature Elimination Predicts Risk of Radiotherapy-Related Fatigue in Patients with Prostate Cancer

Enrique J. deAndrés-Galiana, Juan Luis Fernández-Martínez, J. Fernández-Martínez, 2014, Cancer informatics.

Clinical and other risk indicators for early periodontitis in adults.

R. Kent, S. Sonis, A. Tanner, 2005, Journal of periodontology.

A database for mucositis induced by cancer chemotherapy.

S. Sonis, K. A. Costello, 1995, European journal of cancer. Part B, Oral oncology.

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer

J. Buatti, J. Holmlund, J. Wheeler, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Healing of spontaneous periodontal defects in dogs treated with xenogeneic demineralized bone.

G. Shklar, S. Sonis, R. Williams, 1985, Journal of periodontology.

Radiotherapy-induced severe oral mucositis: pharmacotherapies in recent and current clinical trials

A. Villa, S. Sonis, 2023, Expert opinion on investigational drugs.

Industry and MASCC—an opportunity not to be missed

S. Sonis, J. Epstein, David R. Dean, 2020, Supportive Care in Cancer.

Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity?

S. Sonis, 2019, Supportive Care in Cancer.

MODIFICATION OF IN VITRO AND IN VIVO IMMUNE FUNCTION BY ACUTE INFLAMMATORY CELLS

S. Sonis, M. Rodrick, R. Wilson, 1980, Transplantation.

Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities

Stephen T. Sonis, S. Sonis, Maria L. Mancini, 2014, Front. Pharmacol..

Influence of supernatants from polymorphonuclear leucocytes on blastogenesis of syngeneic and allogeneic murine splenocytes.

S. Sonis, R. Wilson, I. Lamster, 1979, Clinical and experimental immunology.

Capacity of human oral leucocytes to mediate antibody-dependent cell-mediated cytotoxicity.

S. Sonis, I. Lamster, P. Stelos, 1979, Archives of oral biology.

Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.

G. Oster, S. Sonis, M. Vera‐Llonch, 2007, The journal of supportive oncology.

Erratum: MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy (Cancer (2014) 120 (1453-1661))

D. McGuire, L. Elting, S. Sonis, 2015 .

A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis.

M. Lingen, Peili Chen, S. Sonis, 2012, International journal of radiation oncology, biology, physics.

Safety and tolerability of topical clonazepam solution for management of oral dysesthesia.

A. Villa, S. Sonis, J. Kelley, 2017, Oral surgery, oral medicine, oral pathology and oral radiology.

Extraorally delivered photobiomodulation therapy for prevention of oropharyngeal mucositis in pediatric patients undergoing hematopoietic cell transplantation

Anna N. Yaroslavsky, Christine Duncan, Stephen T. Sonis, 2017, BiOS.

Chlorhexidine-induced lingual keratosis and dysplasia in rats.

G. Shklar, S. Sonis, W. B. Clark, 1978, Journal of periodontology.

Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?

S. Sonis, A. Stringer, J. Bowen, 2008, Cancer Chemotherapy and Pharmacology.

Effect of a mouth rinse formulation with human trefoil factor 1-secreting Lactococcus lactis in experimental oral mucositis in hamsters.

S. Sonis, B. Coulie, B. Watkins, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic doxycycline (doxy) lessens rash from dacomitinib (D) an EGFR inhibitor with no rash or diarrhea improvement from corticosteroids or probiotics.

M. Lacouture, A. Jatoi, S. Sonis, 2015 .

Functional “omics” for systems medicine

A. Villa, S. Sonis, 2020 .

Health and Economic Consequences of Mucositis

S. Sonis, 2012 .

Identification of a SNP cluster associated with taxane-induced peripheral neuropathy risk in patients being treated for breast cancer using GWAS data derived from a large cooperative group trial

J. Fernández-Martínez, S. Sonis, B. Schneider, 2023, Supportive Care in Cancer.

Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy

S. Sonis, R. Logan, R. Gibson, 2007 .

New frontiers in mucositis.

S. Sonis, D. Peterson, D. Keefe, 2012, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

PREVLAR: Phase 2a randomized trial to assess the safety and efficacy of RRx-001 in the attenuation of oral mucositis in patients receiving head and neck chemoradiotherapy.

K. Niermann, D. Sher, M. Biagioli, 2023, International journal of radiation oncology, biology, physics.

Oral Toxicity With mTOR Inhibitors in Cancer Therapy

S. George, S. Sonis, M. Gallottini, 2012 .

Effect of topical clonidine on the duration and severity of radiation-induced oral mucositis (OM) in a translational hamster model.

V. Trochon-Joseph, S. Sonis, C. Lemarchand, 2014 .

Exceptional toxicity resistance

A. Villa, S. Sonis, J. Epstein, 2021, Supportive Care in Cancer.

A common infrastructure for real-world patient-reported symptoms: one size fits many

S. Sonis, J. Epstein, C. J. van den Hurk, 2022, Supportive Care in Cancer.

Differential Associations of Rheumatoid Arthritis and Periodontitis or Tooth Loss: A Cross-Sectional Study.

S. Sonis, Y. Farag, Mai Hussein, 2022, Journal of clinical periodontology.

Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).

M. Lacouture, Dong-Wan Kim, B. Cho, 2017, Lung cancer.

Manual of oral and maxillofacial surgery

S. Sonis, 1988 .

Patient-Reported Outcomes

S. Sonis, 2012 .

Avasopasem for the treatment of radiotherapy-induced severe oral mucositis

S. Sonis, C. Anderson, 2023, Expert opinion on investigational drugs.

Dimensional stability of the alveolar ridge after implantation of a bioabsorbable bone graft substitute: a radiographic and histomorphometric study in rats.

S. Sonis, D. Trantolo, W. Jee, 2005, The Journal of oral implantology.

Clinical trial of demineralized bone powder in the treatment of periodontal defects.

J. Glowacki, S. Sonis, L. Kaban, 1983, Journal of oral medicine.

Emerging drugs for chemotherapy-induced mucositis.

S. Sonis, J. Bowen, D. Keefe, 2008, Expert Opinion on Emerging Drugs.

Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.

C. Scully, S. Sonis, J. Epstein, 2003, Head & neck.

Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study.

A. Villa, S. Sonis, J. Kelley, 2017, Journal of oral & facial pain and headache.

The use of infrared thermography in the evaluation of oral lesions.

P. Lockhart, S. Sonis, B. A. White, 1986, Journal of the American Dental Association.

Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-D-glutamyl-L-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis.

G. Alterovitz, S. Sonis, C. Tuthill, 2011, Oral oncology.

Introduction to Modern Cancer Diagnosis and Survivorship

S. Sonis, R. Nair, Rami Nair, 2022, Orofacial Supportive Care in Cancer.

AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis.

S. Sonis, B. Coulie, S. Neirynck, 2010, Oral oncology.

Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis?

S. Sonis, Rui Amaral Mendes, 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

D. McGuire, L. Elting, S. Sonis, 2014, Cancer.

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

R. Tishler, A. Mahadevan, A. Allen, 2009, Cancer.

Two-Year Tumor Outcomes of Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiation Therapy and Ciplatin for Head and Neck Cancer.

J. Holmlund, N. Dunlap, V. Bar-ad, 2022, International journal of radiation oncology, biology, physics.

A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.

M. Lacouture, A. Jatoi, S. Sonis, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers

A. Villa, S. Sonis, Michele Vollemans, 2021, Supportive Care in Cancer.

Oral and Maxillofacial Medicine

S. Sonis, 2009 .

Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05)Reduces the Severity and Duration of Oral Mucositis.

S. Sonis, E. Fey, B. Watkins, 2005, Supportive cancer therapy.

Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters

S. Sonis, E. Fey, C. Murphy, 2008, Clinical Cancer Research.

Severe oral mucositis (SOM) mitigation by genetically modified lactococcus lactis bacteria (LLB) producing human trefoil factor 1 (hTFF1; AG013) in patients being treated with concomitant chemoradiation (CRT) for oral and oropharyngeal cancers (OCOPC)

Yuhchyau Chen, S. Sonis, S. Thatcher, 2019, Annals of Oncology.